Sivik Global Healthcare LLC In its 13F for Q1 2025 (holdings as of March 31, 2025, filed April 22, 2025), Sivik Global Healthcare LLC reported 29 stock positions worth $182.9 million . Its top holding was SS SPDR S&P Biotech ETF (XBI) at 11.1% of the portfolio, followed by Boston Scientific (BSX, 5.5% ) and Tenet Healthcare (THC, 5.1% ). Compared with Q4 2024, it opened 6 new positions, sold out of 13, added to 10 and reduced 9. The biggest buy was a new position in Intuitive Surgical (ISRG) and the biggest sale an exit from Vertex Pharmaceuticals (VRTX).
Location GREENWICH, CT
CIK 0001596452
Portfolio Value $182.9M (Q1 2025) Holdings 29 stocks · $182.9M Holdings quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock % Of Portfolio ▼ Shares Held Total Value Change vs Q4 2024 XBI SS SPDR S&P Biotech ETF 11.08% 250,000 $20.3M Add +25.0% BSX Boston Scientific Corp. 5.51% 100,000 $10.1M Reduce -9.1% THC Tenet Healthcare Corp. 5.15% 70,000 $9.4M Add +27.3% HCA HCA Healthcare Inc. 4.72% 25,000 $8.6M Add +25.0% LLY Eli Lilly & Co. 4.06% 9,000 $7.4M Reduce -40.0% MCK McKesson Corp. 4.05% 11,000 $7.4M Reduce -26.7% DHR Danaher Corp. 3.92% 35,000 $7.2M Add +40.0% COR Cencora Inc. 3.80% 25,000 $7.0M No change ISRG Intuitive Surgical Inc. 3.79% 14,000 $6.9M New CAH Cardinal Health Inc. 3.77% 50,000 $6.9M No change MDT Medtronic PLC 3.68% 75,000 $6.7M New SYK Stryker Corp. 3.56% 17,500 $6.5M Reduce -12.5% WAT Waters Corp. 3.43% 17,000 $6.3M Add +21.4% UHS Universal Health Services-B 3.34% 32,500 $6.1M Reduce -13.3% HUM Humana Inc. 3.33% 23,000 $6.1M Add +15.0% BAX Baxter International Inc. 3.27% 175,000 $6.0M New ABT Abbott Laboratories 3.26% 45,000 $6.0M Reduce -10.0% A Agilent Technologies Inc. 3.20% 50,000 $5.8M Add +42.9% EHC Encompass Health Corp. 2.86% 51,600 $5.2M Add +14.7% AZN Astrazeneca PLC-Spons ADR 2.81% 70,000 $5.1M New NVO Novo-Nordisk A/S-Spons ADR 2.66% 70,000 $4.9M No change GILD Gilead Sciences Inc. 2.45% 40,000 $4.5M New CI The Cigna Group 2.25% 12,500 $4.1M Add +4.2% SNN Smith & Nephew PLC -Spon ADR 1.86% 120,000 $3.4M Reduce -4.0% SEM Select Medical Holdings Corp. 1.83% 200,000 $3.3M Add +33.3% AVTR Avantor Inc. 1.77% 200,000 $3.2M No change SGRY Surgery Partners Inc. 1.62% 125,000 $3.0M Reduce -37.5% WST West Pharmaceutical Services 1.53% 12,500 $2.8M New UNH Unitedhealth Group Inc. 1.43% 5,000 $2.6M Reduce -60.0%
Options reported separately and not counted above: SRPT puts ($1.3M), PUT - SPY 100 @ 570 EXP 04/17/2025 puts ($755K).
Portfolio Sells Q4 2024 → Q1 2025 Portfolio Sells quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q4 2024 % Of Portfolio Change To Portfolio ▲ VRTX Vertex Pharmaceuticals Inc. Sold out 0.00% −2.89 ABBV Abbvie Inc. Sold out 0.00% −2.46 LLY Eli Lilly & Co. Reduce -40.0% 4.06% −2.34 BMY Bristol-Myers Squibb Co. Sold out 0.00% −2.19 UNH Unitedhealth Group Inc. Reduce -60.0% 1.43% −2.06 EW Edwards Lifesciences Corp. Sold out 0.00% −2.05 BIO Bio-Rad Laboratories-A Sold out 0.00% −1.82 ZTS Zoetis Inc. Sold out 0.00% −1.35 ZBH Zimmer Biomet Holdings Inc. Sold out 0.00% −1.17 ACHC Acadia Healthcare Co. Inc. Sold out 0.00% −1.10 BNTX Biontech SE-ADR Sold out 0.00% −0.94 ALNY Alnylam Pharmaceuticals Inc. Sold out 0.00% −0.91 RGEN Repligen Corp. Sold out 0.00% −0.80 SGRY Surgery Partners Inc. Reduce -37.5% 1.62% −0.72 MCK McKesson Corp. Reduce -26.7% 4.05% −0.68 SRPT Sarepta Therapeutics Inc. Sold out 0.00% −0.67 MRVI Maravai Lifesciences Hldgs-A Sold out 0.00% −0.42 SYK Stryker Corp. Reduce -12.5% 3.56% −0.42 UHS Universal Health Services-B Reduce -13.3% 3.34% −0.38 BSX Boston Scientific Corp. Reduce -9.1% 5.51% +0.08 ABT Abbott Laboratories Reduce -10.0% 3.26% +0.14 SNN Smith & Nephew PLC -Spon ADR Reduce -4.0% 1.86% +0.16
Portfolio Buys Q4 2024 → Q1 2025 Portfolio Buys quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q4 2024 % Of Portfolio Change To Portfolio ▼ ISRG Intuitive Surgical Inc. New 3.79% +3.79 MDT Medtronic PLC New 3.68% +3.68 BAX Baxter International Inc. New 3.27% +3.27 AZN Astrazeneca PLC-Spons ADR New 2.81% +2.81 GILD Gilead Sciences Inc. New 2.45% +2.45 WST West Pharmaceutical Services New 1.53% +1.53 HCA HCA Healthcare Inc. Add +25.0% 4.72% +1.40 THC Tenet Healthcare Corp. Add +27.3% 5.15% +1.31 XBI SS SPDR S&P Biotech ETF Add +25.0% 11.08% +1.12 DHR Danaher Corp. Add +40.0% 3.92% +0.75 A Agilent Technologies Inc. Add +42.9% 3.20% +0.60 EHC Encompass Health Corp. Add +14.7% 2.86% +0.56 WAT Waters Corp. Add +21.4% 3.43% +0.55 HUM Humana Inc. Add +15.0% 3.33% +0.52 CI The Cigna Group Add +4.2% 2.25% +0.42 SEM Select Medical Holdings Corp. Add +33.3% 1.83% +0.26
Options Activity Q4 2024 → Q1 2025 Security Type Change vs Q4 2024 Underlying Shares Value ▼ ISRG Intuitive Surgical Inc. put Sold out 15,000 $7.8Mbefore exit SRPT Sarepta Therapeutics Inc. put New 20,000 $1.3M MDGL Madrigal Pharmaceuticals Inc. put Sold out 4,000 $1.2Mbefore exit PUT - SPY 100 @ 570 EXP 04/17/2025 put New 500 $755K
Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
All Filings Quarter Positions 13F Reported Value Top Holdings Q2 2026 34 $131.7M XBI, CAH, CALL- BSX 100 @ 75 EXP 04/17/2026, JNJ, MRK Q1 2026 34 $131.7M XBI, CAH, CALL- BSX 100 @ 75 EXP 04/17/2026, JNJ, MRK Q4 2025 41 $204.8M XBI, LLY, THC, MCK, HCA Q3 2025 35 $190.5M XBI, LLY, HCA, THC, DHR Q2 2025 38 $223.6M XBI, THC, HCA, MCK, UHS Q1 2025 29 $182.9M XBI, BSX, THC, HCA, LLY Q4 2024 36 $180.8M XBI, LLY, BSX, MCK, SYK Q3 2024 33 $234.6M XBI, LLY, THC, NVO, UHS Q2 2024 37 $223.9M LLY, NVO, MCK, THC, BSX Q1 2024 46 $275.1M XBI, LLY, NVO, BSX, TMO